10.6084/m9.figshare.11974503.v2
Jennie H. Best
Jennie H.
Best
Steven C. Vlad
Steven C.
Vlad
Lenore Tominna
Lenore
Tominna
Ibrahim Abbass
Ibrahim
Abbass
Real-World Persistence with Tocilizumab Compared to Other Subcutaneous Biologic Disease-Modifying Antirheumatic Drugs Among Patients with Rheumatoid Arthritis Switching from Another Biologic
Adis Journals
2020
Biologic
Persistence
Real-world
Rheumatoid arthritis
Tocilizumab
2020-03-25 10:01:17
Figure
https://adisjournals.figshare.com/articles/figure/Real-World_Persistence_of_Tocilizumab_Compared_With_Other_Subcutaneous_Biologic_Disease-Modifying_Antirheumatic_Drugs_Among_Patients_With_Rheumatoid_Arthritis_Switching_From_Another_Biologic/11974503
<p>The above summary slide represents the opinions of
the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite).<br></p>
<p>© The authors, CC-BY-NC 2020.<b>
</b></p>